Before any strategy can be formulated for next year’s appropriations, cancer groups must confront the formidable challenge of figuring out how much of President Joe Biden’s vision for cancer research is realistic.
The FY22 spending bill increases NCI’s budget by $159 million—but according to NCI officials, this boost isn’t sufficient to raise paylines for R01 grants for established and new investigators.
Congress has extended FY22 spending talks once again, leaving the proposed Advanced Research Projects Agency for Health (ARPA-H)—a key piece of President Joe Biden’s cancer agenda—in limbo.
President Biden has been describing the Advanced Research Projects Agency for Health (ARPA-H), a DARPA-like biomedical research agency, as the centerpiece of his effort to “end cancer as we know it.”
Congress needs to increase the FY22 base budgets of NIH and NCI by $3.2 billion and $1.1 billion, respectively, over FY21 levels, the American Association for Cancer Research said in its 2021 Cancer Progress Report.
Women who report sexual misconduct to NIH may find that their complaints have a limited shelf life—these complaints may become null, or at least ineligible for “even a cursory review” once perpetrators cut ties with NIH.
A Congressional letter is asking NIH to describe the procedures employed for rooting out sexual misconduct committed by advisors.
Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law
Institutions receiving NIH funds through grants or cooperative agreements would be required—by federal law—to notify the NIH director when a principal investigator or other key personnel are removed or disciplined for “harassment, bullying, retaliation, or hostile working conditions.”
A House appropriations subcommittee voted to increase NIH’s FY2022 budget by $6.5 billion—to $46.43 billion—which falls $2.5 billion short of President Joe Biden’s request for NIH.
The FY22 budget proposed by the White House doesn’t include sufficient funds to sustainably support NCI researchers, even though the proposal includes the largest ever funding increase for NIH, the American Association for Cancer Research said in a letter to House appropriators.
